Rheumatic fever recurrence prevention: a nurse-led programme of 28-day penicillin in an area of high endemnicity.
about
Invasive group A streptococcal infection and vaccine implications, Auckland, New ZealandImprovement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approachWorld Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline.Low adherence to secondary prophylaxis among clients diagnosed with rheumatic fever, Jamaica.Throat culture positivity rate and antibiotic susceptibility pattern of beta-hemolytic streptococci in children on secondary prophylaxis for rheumatic heart diseaseRheumatic fever in New Zealand.Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease.Secondary prophylaxis for rheumatic fever: simple concepts, difficult delivery.An immunological perspective on rheumatic heart disease pathogenesis: more questions than answers.Adherence to secondary prophylaxis for acute rheumatic fever and rheumatic heart disease: a systematic review.Failure of oral penicillin as secondary prophylaxis for rheumatic heart disease: a lesson from a low-prevalence rheumatic fever region.Family acceptability of school-based echocardiographic screening for rheumatic heart disease in a high-risk population in New Zealand.Incidence of acute rheumatic fever in New Zealand children and youth.Mortality and hospitalisation costs of rheumatic fever and rheumatic heart disease in New Zealand.Acute rheumatic fever and rheumatic heart disease.Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review.
P2860
Q28729759-739DAA9A-0DFF-437D-97BC-37E4E4FC5CC8Q30561289-393F0BB9-00D7-4E4D-960B-39CE458E6101Q33924517-7CF053DF-C92D-4AB7-8746-B806B8221DCCQ34129679-AFE0726E-BE98-472F-82C8-254004EA376FQ36143527-A7A42A3B-05C3-416C-8F9B-538035BA4431Q37952334-822FDE76-619C-4BDA-977B-4786B89234FCQ38094958-80F7FDA3-CB0F-4802-9B59-DF6A2CFE983FQ38170351-4B299E19-0E14-4928-9B18-98F9640E3EBBQ38853407-B54E91F8-95D1-48EC-8C91-00DACBA9C316Q39091590-3188A537-DCC4-4ED6-A9ED-F9024D7FD14FQ40132685-DF050692-7C1D-4914-AF10-88D534C18296Q40165932-3A028F32-ED8D-42F6-A1EE-D27948D9686EQ40290576-521CEE8E-6D04-4247-B57E-C2CDF7AB1098Q40290583-A8F017BD-C988-48B1-B826-FAA1256EF525Q47429720-A226E434-5F02-4644-A324-7747959A29C2Q55075601-85752659-3D0C-4FFD-B0BA-4FA9F269F298
P2860
Rheumatic fever recurrence prevention: a nurse-led programme of 28-day penicillin in an area of high endemnicity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rheumatic fever recurrence pre ...... n an area of high endemnicity.
@en
Rheumatic fever recurrence pre ...... n an area of high endemnicity.
@nl
type
label
Rheumatic fever recurrence pre ...... n an area of high endemnicity.
@en
Rheumatic fever recurrence pre ...... n an area of high endemnicity.
@nl
prefLabel
Rheumatic fever recurrence pre ...... n an area of high endemnicity.
@en
Rheumatic fever recurrence pre ...... n an area of high endemnicity.
@nl
P2093
P2860
P1476
Rheumatic fever recurrence pre ...... n an area of high endemnicity.
@en
P2093
Diana Lennon
Heather Spinetto
Margaret Horsburgh
P2860
P304
P356
10.1111/J.1440-1754.2010.01942.X
P577
2011-04-06T00:00:00Z